Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

October 01, 2014; Volume 66,Issue 4

IUPHAR Nomenclature Report

  • You have access
    International Union of Basic and Clinical Pharmacology. XC. Multisite Pharmacology: Recommendations for the Nomenclature of Receptor Allosterism and Allosteric Ligands
    Arthur Christopoulos, Jean-Pierre Changeux, William A. Catterall, Doriano Fabbro, Thomas P. Burris, John A. Cidlowski, Richard W. Olsen, John A. Peters, Richard R. Neubig, Jean-Philippe Pin, Patrick M. Sexton, Terry P. Kenakin, Frederick J. Ehlert, Michael Spedding and Christopher J. Langmead
    Eliot H. Ohlstein, ASSOCIATE EDITOR
    Pharmacological Reviews October 2014, 66 (4) 918-947; DOI: https://doi.org/10.1124/pr.114.008862

Review Articles

  • You have access
    Bile Acid Signaling in Metabolic Disease and Drug Therapy
    Tiangang Li and John Y. L. Chiang
    Qiang Ma, ASSOCIATE EDITOR
    Pharmacological Reviews October 2014, 66 (4) 948-983; DOI: https://doi.org/10.1124/pr.113.008201
  • You have access
    Novel and Conventional Receptors for Ghrelin, Desacyl-Ghrelin, and Pharmacologically Related Compounds
    Brid Callaghan and John B. Furness
    Arthur Christopoulos, ASSOCIATE EDITOR
    Pharmacological Reviews October 2014, 66 (4) 984-1001; DOI: https://doi.org/10.1124/pr.113.008433
  • You have access
    Targeting the Modulation of Neural Circuitry for the Treatment of Anxiety Disorders
    David H. Farb and Marcia H. Ratner
    Leslie A. Morrow, ASSOCIATE EDITOR
    Pharmacological Reviews October 2014, 66 (4) 1002-1032; DOI: https://doi.org/10.1124/pr.114.009126
  • You have access
    Phospholipase D Signaling Pathways and Phosphatidic Acid as Therapeutic Targets in Cancer
    Ronald C. Bruntz, Craig W. Lindsley and H. Alex Brown
    David R. Sibley, ASSOCIATE EDITOR
    Pharmacological Reviews October 2014, 66 (4) 1033-1079; DOI: https://doi.org/10.1124/pr.114.009217
  • You have access
    Mas and Its Related G Protein–Coupled Receptors, Mrgprs
    Michael Bader, Natalia Alenina, Miguel A. Andrade-Navarro and Robson A. Santos
    Dianne M. Perez, ASSOCIATE EDITOR
    Pharmacological Reviews October 2014, 66 (4) 1080-1105; DOI: https://doi.org/10.1124/pr.113.008136
  • You have access
    The Pharmacology of the Cytochrome P450 Epoxygenase/Soluble Epoxide Hydrolase Axis in the Vasculature and Cardiovascular Disease
    Ingrid Fleming
    Ulf Simonsen, ASSOCIATE EDITOR
    Pharmacological Reviews October 2014, 66 (4) 1106-1140; DOI: https://doi.org/10.1124/pr.113.007781
  • You have access
    Interaction of Risk Factors, Comorbidities, and Comedications with Ischemia/Reperfusion Injury and Cardioprotection by Preconditioning, Postconditioning, and Remote Conditioning
    Péter Ferdinandy, Derek J. Hausenloy, Gerd Heusch, Gary F. Baxter and Rainer Schulz
    Finn Olav Levy, ASSOCIATE EDITOR
    Pharmacological Reviews October 2014, 66 (4) 1142-1174; DOI: https://doi.org/10.1124/pr.113.008300

Erratum

  • You have access
    Correction to “Glutamate Receptor Ion Channels: Structure, Regulation, and Function”
    Pharmacological Reviews October 2014, 66 (4) 1141; DOI: https://doi.org/10.1124/pr.113.002451err
Back to top
PreviousNext

In this issue

Pharmacological Reviews: 66 (4)
Pharmacological Reviews
Vol. 66, Issue 4
1 Oct 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • IUPHAR Nomenclature Report
  • Review Articles
  • Erratum
  • Most Cited
  • Most Read
Loading
  • Nitric oxide: physiology, pathophysiology, and pharmacology.
  • The Glutamate Receptor Ion Channels
  • Receptors for Purines and Pyrimidines
  • Evolving Concepts in G Protein-Coupled Receptor Endocytosis: The Role in Receptor Desensitization and Signaling
  • Glutamate Receptor Ion Channels: Structure, Regulation, and Function
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics